BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 33515668)

  • 1. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group.
    Lacas B; Carmel A; Landais C; Wong SJ; Licitra L; Tobias JS; Burtness B; Ghi MG; Cohen EEW; Grau C; Wolf G; Hitt R; Corvò R; Budach V; Kumar S; Laskar SG; Mazeron JJ; Zhong LP; Dobrowsky W; Ghadjar P; Fallai C; Zakotnik B; Sharma A; Bensadoun RJ; Ruo Redda MG; Racadot S; Fountzilas G; Brizel D; Rovea P; Argiris A; Nagy ZT; Lee JW; Fortpied C; Harris J; Bourhis J; Aupérin A; Blanchard P; Pignon JP;
    Radiother Oncol; 2021 Mar; 156():281-293. PubMed ID: 33515668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of chemotherapy in 5000 patients with head and neck cancer treated by curative surgery: A subgroup analysis of the meta-analysis of chemotherapy in head and neck cancer.
    Dauzier E; Lacas B; Blanchard P; Le QT; Simon C; Wolf G; Janot F; Horiuchi M; Tobias JS; Moon J; Simes J; Deshmane V; Mazeron JJ; Mehta S; Zaktonik B; Tamura M; Moyal E; Licitra L; Fortpied C; Haffty BG; Ghi MG; Gregoire V; Harris J; Bourhis J; Aupérin A; Pignon JP;
    Oral Oncol; 2019 Aug; 95():106-114. PubMed ID: 31345376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients.
    Pignon JP; le Maître A; Maillard E; Bourhis J;
    Radiother Oncol; 2009 Jul; 92(1):4-14. PubMed ID: 19446902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer.
    Pignon JP; Bourhis J; Domenge C; Designé L
    Lancet; 2000 Mar; 355(9208):949-55. PubMed ID: 10768432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy and radiotherapy in locally advanced head and neck cancer: an individual patient data network meta-analysis.
    Petit C; Lacas B; Pignon JP; Le QT; Grégoire V; Grau C; Hackshaw A; Zackrisson B; Parmar MKB; Lee JW; Ghi MG; Sanguineti G; Temam S; Cheugoua-Zanetsie M; O'Sullivan B; Posner MR; Vokes EE; Cruz Hernandez JJ; Szutkowski Z; Lartigau E; Budach V; Suwiński R; Poulsen M; Kumar S; Ghosh Laskar S; Mazeron JJ; Jeremic B; Simes J; Zhong LP; Overgaard J; Fortpied C; Torres-Saavedra P; Bourhis J; Aupérin A; Blanchard P;
    Lancet Oncol; 2021 May; 22(5):727-736. PubMed ID: 33862002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis.
    Lacas B; Bourhis J; Overgaard J; Zhang Q; Grégoire V; Nankivell M; Zackrisson B; Szutkowski Z; Suwiński R; Poulsen M; O'Sullivan B; Corvò R; Laskar SG; Fallai C; Yamazaki H; Dobrowsky W; Cho KH; Beadle B; Langendijk JA; Viegas CMP; Hay J; Lotayef M; Parmar MKB; Aupérin A; van Herpen C; Maingon P; Trotti AM; Grau C; Pignon JP; Blanchard P;
    Lancet Oncol; 2017 Sep; 18(9):1221-1237. PubMed ID: 28757375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): a comprehensive analysis by tumour site.
    Blanchard P; Baujat B; Holostenco V; Bourredjem A; Baey C; Bourhis J; Pignon JP;
    Radiother Oncol; 2011 Jul; 100(1):33-40. PubMed ID: 21684027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell carcinoma of the head and neck (HNSCC): A meta-analysis of randomized trials.
    Budach W; Bölke E; Kammers K; Gerber PA; Orth K; Gripp S; Matuschek C
    Radiother Oncol; 2016 Feb; 118(2):238-43. PubMed ID: 26589131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis.
    Blanchard P; Lee A; Marguet S; Leclercq J; Ng WT; Ma J; Chan AT; Huang PY; Benhamou E; Zhu G; Chua DT; Chen Y; Mai HQ; Kwong DL; Cheah SL; Moon J; Tung Y; Chi KH; Fountzilas G; Zhang L; Hui EP; Lu TX; Bourhis J; Pignon JP;
    Lancet Oncol; 2015 Jun; 16(6):645-55. PubMed ID: 25957714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction chemotherapy decreases the rate of distant metastasis in patients with head and neck squamous cell carcinoma but does not improve survival or locoregional control: a meta-analysis.
    Ma J; Liu Y; Huang XL; Zhang ZY; Myers JN; Neskey DM; Zhong LP
    Oral Oncol; 2012 Nov; 48(11):1076-84. PubMed ID: 22800881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Season of radiotherapy and outcomes of head & neck cancer patients in the MACH-NC & MARCH meta-analyses.
    Limkin E; Blanchard P; Lacas B; Bourhis J; Parmar M; Licitra L; Le QT; Yom SS; Fortpied C; Langendijk J; Vermorken JB; Bernier J; Overgaard J; Harris J; Pignon JP; Auperin A;
    Radiother Oncol; 2024 Jan; 190():110011. PubMed ID: 37956890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concomitant radiochemotherapy or accelerated radiotherapy: analysis of two randomized trials of the French Head and Neck Cancer Group (GORTEC).
    Bourhis J; Calais G; Lapeyre M; Tortochaux J; Alfonsi M; Sire C; Bardet E; Rives M; Bergerot P; Rhein B; Desprez B;
    Semin Oncol; 2004 Dec; 31(6):822-6. PubMed ID: 15599861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck.
    Merlano M; Benasso M; Corvò R; Rosso R; Vitale V; Blengio F; Numico G; Margarino G; Bonelli L; Santi L
    J Natl Cancer Inst; 1996 May; 88(9):583-9. PubMed ID: 8609658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del Collo.
    Paccagnella A; Orlando A; Marchiori C; Zorat PL; Cavaniglia G; Sileni VC; Jirillo A; Tomio L; Fila G; Fede A
    J Natl Cancer Inst; 1994 Feb; 86(4):265-72. PubMed ID: 8158680
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive classifier for intensive treatment of head and neck cancer.
    Zakeri K; Rotolo F; Lacas B; Vitzthum LK; Le QT; Gregoire V; Overgaard J; Hackshaw A; Zackrisson B; Parmar MKB; Burtness BA; Ghi MG; Sanguineti G; O'Sullivan B; Fortpied C; Bourhis J; Shen H; Harris J; Michiels S; Pignon JP; Mell LK;
    Cancer; 2020 Dec; 126(24):5263-5273. PubMed ID: 33017867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locally advanced squamous cell carcinoma of the head and neck: A systematic review and Bayesian network meta-analysis of the currently available treatment options.
    Iocca O; Farcomeni A; Di Rocco A; Di Maio P; Golusinski P; Pardiñas López S; Savo A; Pellini R; Spriano G
    Oral Oncol; 2018 May; 80():40-51. PubMed ID: 29706187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Taxane-cisplatin-fluorouracil as induction chemotherapy in locally advanced head and neck cancers: an individual patient data meta-analysis of the meta-analysis of chemotherapy in head and neck cancer group.
    Blanchard P; Bourhis J; Lacas B; Posner MR; Vermorken JB; Cruz Hernandez JJ; Bourredjem A; Calais G; Paccagnella A; Hitt R; Pignon JP;
    J Clin Oncol; 2013 Aug; 31(23):2854-60. PubMed ID: 23835714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
    Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
    Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interventions for the treatment of oral cavity and oropharyngeal cancer: chemotherapy.
    Furness S; Glenny AM; Worthington HV; Pavitt S; Oliver R; Clarkson JE; Macluskey M; Chan KK; Conway DI;
    Cochrane Database Syst Rev; 2010 Sep; (9):CD006386. PubMed ID: 20824847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Very accelerated radiotherapy or concurrent chemoradiotherapy for N3 head and neck squamous cell carcinoma: Pooled analysis of two GORTEC randomized trials.
    Tao Y; Aupérin A; Graff P; Lapeyre M; Grégoire V; Maingon P; Geoffrois L; Verrelle P; Calais G; Gery B; Martin L; Alfonsi M; Deprez P; Bardet E; Pignon T; Rives M; Sire C; Bourhis J
    Oral Oncol; 2017 Aug; 71():61-66. PubMed ID: 28688693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.